PAIN
Volume 149, Issue 2 , Pages 316-324 , May 2010

Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin

Received 7 September 2009 ,Revised 20 January 2010 ,Accepted 16 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0304-3959(10)00116-8

doi: 10.1016/j.pain.2010.02.024

PAIN
Volume 149, Issue 2 , Pages 316-324 , May 2010

Article Tools

* Image Usage & Resolution